Skip to content

Efficacy of auricular therapy in preventing intrapartum fever during labor analgesia: a single-center, double-blind ,randomized controlled trial

Clinical study on the effect of auricular therapy on intrapartum fever during labor analgesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000763
Enrollment
Unknown
Registered
2026-03-27
Start date
2025-09-03
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intrapartum fever durring labor analgesia

Interventions

test group:Auricular acupressure with Vaccaria seeds was uniformly applied to specific acupoints on the right ear of parturient women.
control group:Sham auricular tapes (Vaccaria seed-removed) were applied to matched auricular acupoints.

Sponsors

Women's Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) ASA Physical Status Class I-II (2) Age 18-40 years (3) Body mass index (BMI) <30 kg/m² (4) Gestational age =37 weeks (5) Primiparous women with singleton cephalic presentation (6) Request for epidural analgesia at cervical dilation =3 cm (7) Afebrile status (=37.2°C) upon labor room admission and no febrile history within one week (8) Absence of contraindications to epidural anesthesia (9) Without hypertensive disorders of pregnancy (10) Normal fetal heart rate monitoring prior to analgesia (120-160 bpm)

Exclusion criteria

Exclusion criteria: (1) Cephalopelvic disproportion or pelvic deformities (2) Cervical dilation >3 cm at the time of labor analgesia request (3) Contraindications to neuraxial anesthesia (e.g. coagulopathy local infection at puncture site) (4) Opioid or other sedative/analgesic use within one week (5) Current magnesium sulfate administration (6) History of substance abuse (7) Severe cardiopulmonary/hepatic/renal dysfunction (8) Active infection within two weeks or recent antibiotic use

Design outcomes

Primary

MeasureTime frame
maternal intrapartum fever incidence rate;

Secondary

MeasureTime frame
Maternal temperature ;pain NRS score;analgesic consumption and number of effective PCEA demands;duration and method of membrane rupture;number of vaginal examinations;Obstetric outcome;Neonatal outcome;Concentrations of inflammatory factors (IL-6, IL-1ß, and TNF-a);

Countries

China

Contacts

Public ContactShiqin Xu

Women's Hospital of Nanjing Medical University

xusqnj@126.com13951660028

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026